Review
World J Pharmacol
3(4):39-55.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.39
Abstract (1517)
|
Core Tip (1221)
|
Full Article (HTML) (12877)
|
Figures (1-3) (188)
|
Tables (1-5) (208)
|
Full Article (PDF)-1451K (1137)
|
Peer-Review Report-94K (327)
|
Answering Reviewers-72K (251)
|
Received: 06/26/2014
|
Revised: 09/09/2014
|
Accepted: 10/10/2014
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (54)
|
Total Visits (23489)
|
Similar Articles (6)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):56-71.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.56
Abstract (1505)
|
Core Tip (1205)
|
Full Article (HTML) (7908)
|
Figures (1-1) (266)
|
Tables (1-3) (170)
|
Full Article (PDF)-1210K (634)
|
Peer-Review Report-98K (279)
|
Answering Reviewers-99K (229)
|
Received: 07/01/2014
|
Revised: 08/01/2014
|
Accepted: 09/17/2014
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (15261)
|
Similar Articles (148)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):72-85.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.72
Abstract (1371)
|
Core Tip (1187)
|
Full Article (HTML) (8775)
|
Figures (1-4) (471)
|
Tables (1-1) (158)
|
Full Article (PDF)-1374K (978)
|
Peer-Review Report-105K (265)
|
Answering Reviewers-58K (324)
|
Received: 07/28/2014
|
Revised: 08/29/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (16809)
|
Similar Articles (6)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):86-96.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.86
Abstract (1210)
|
Core Tip (1175)
|
Full Article (HTML) (6149)
|
Figures (1-3) (249)
|
Full Article (PDF)-2317K (704)
|
Peer-Review Report-102K (263)
|
Answering Reviewers-250K (326)
|
Received: 07/28/2014
|
Revised: 10/01/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (12879)
|
Similar Articles (2)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):97-109.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.97
Abstract (1015)
|
Core Tip (883)
|
Full Article (HTML) (4234)
|
Figures (1-1) (161)
|
Tables (1-4) (168)
|
Full Article (PDF)-1455K (610)
|
Peer-Review Report-129K (154)
|
Answering Reviewers-81K (177)
|
Received: 06/28/2014
|
Revised: 10/02/2014
|
Accepted: 11/10/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (9954)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Harnessing pharmacological knowledge for personalized medicine and pharmacotyping: Challenges and lessons learned
World J Pharmacol
3(4):110-119.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.110
Abstract (1125)
|
Core Tip (877)
|
Full Article (HTML) (3311)
|
Figures (1-1) (201)
|
Tables (1-1) (173)
|
Full Article (PDF)-2534K (452)
|
Peer-Review Report-98K (218)
|
Answering Reviewers-19K (150)
|
Received: 06/12/2014
|
Revised: 07/03/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (9816)
|
Similar Articles (4)
|
Timeline of Article Publication (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):120-139.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.120
Abstract (1395)
|
Core Tip (1053)
|
Full Article (HTML) (7358)
|
Figures (1-2) (227)
|
Tables (1-1) (129)
|
Full Article (PDF)-1376K (613)
|
Peer-Review Report-116K (298)
|
Answering Reviewers-78K (294)
|
Received: 06/29/2014
|
Revised: 09/01/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (16778)
|
Similar Articles (59)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):140-152.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.140
Abstract (1316)
|
Core Tip (1175)
|
Full Article (HTML) (6284)
|
Figures (1-2) (121)
|
Tables (1-1) (120)
|
Full Article (PDF)-2415K (424)
|
Peer-Review Report-106K (336)
|
Answering Reviewers-72K (203)
|
Received: 06/27/2014
|
Revised: 10/02/2014
|
Accepted: 11/03/2014
|
CrossRef
|
Google Scholar
|
Times Cited (13)
|
Total Visits (12613)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(1)
|
Open
Minireviews
Pharmacological role of efflux transporters: Clinical implications for medication use during breastfeeding
World J Pharmacol
3(4):153-161.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.153
Abstract (1198)
|
Core Tip (1090)
|
Full Article (HTML) (4782)
|
Figures (1-1) (157)
|
Full Article (PDF)-1040K (513)
|
Peer-Review Report-104K (251)
|
Answering Reviewers-60K (198)
|
Received: 06/28/2014
|
Revised: 09/03/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (11176)
|
Similar Articles (8)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):162-173.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.162
Abstract (1268)
|
Core Tip (1264)
|
Full Article (HTML) (5716)
|
Figures (1-2) (187)
|
Tables (1-1) (125)
|
Full Article (PDF)-4747K (701)
|
Peer-Review Report-116K (300)
|
Answering Reviewers-128K (284)
|
Received: 06/27/2014
|
Revised: 08/07/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (15067)
|
Similar Articles (2)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):174-185.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.174
Abstract (1005)
|
Core Tip (817)
|
Full Article (HTML) (3616)
|
Tables (1-1) (160)
|
Full Article (PDF)-1054K (330)
|
Peer-Review Report-106K (233)
|
Answering Reviewers-75K (160)
|
Received: 07/29/2014
|
Revised: 10/02/2014
|
Accepted: 10/27/2014
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (8905)
|
Similar Articles (16)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):186-192.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.186
Abstract (1174)
|
Core Tip (925)
|
Full Article (HTML) (5758)
|
Tables (1-2) (148)
|
Full Article (PDF)-872K (569)
|
Peer-Review Report-82K (262)
|
Answering Reviewers-100K (226)
|
Received: 05/16/2014
|
Revised: 07/04/2014
|
Accepted: 09/17/2014
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (12953)
|
Similar Articles (28)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Therapeutics Advances
World J Pharmacol
3(4):193-198.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.193
Abstract (1015)
|
Core Tip (784)
|
Full Article (HTML) (1967)
|
Figures (1-2) (112)
|
Tables (1-1) (128)
|
Full Article (PDF)-1053K (282)
|
Peer-Review Report-98K (249)
|
Answering Reviewers-31K (151)
|
Received: 06/24/2014
|
Revised: 09/22/2014
|
Accepted: 10/10/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (9784)
|
Similar Articles (713)
|
Timeline of Article Publication (2)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Evidence-Based Medicine
World J Pharmacol
3(4):199-208.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.199
Abstract (1168)
|
Core Tip (1023)
|
Full Article (HTML) (5930)
|
Tables (1-4) (194)
|
Full Article (PDF)-1067K (529)
|
Peer-Review Report-118K (252)
|
Answering Reviewers-113K (263)
|
Received: 07/28/2014
|
Revised: 09/08/2014
|
Accepted: 10/16/2014
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (12632)
|
Similar Articles (70)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Systematic Reviews
Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue?
World J Pharmacol
3(4):209-216.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.209
Abstract (1169)
|
Core Tip (914)
|
Full Article (HTML) (7889)
|
Figures (1-1) (155)
|
Tables (1-2) (145)
|
Full Article (PDF)-1014K (391)
|
Peer-Review Report-80K (234)
|
Answering Reviewers-67K (188)
|
Received: 05/21/2014
|
Revised: 07/14/2014
|
Accepted: 10/27/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (14420)
|
Similar Articles (198)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open